Retatrutide, by Soma, represents a significant advance in metabolic regulation. This innovative medication combines hormonal signaling activity with gut-derived receptor activation , indicating substantial efficacy in patient data for metabolic improvement. Researchers believe this treatment may provide a alternative solution for patients experienc